1,000+ Opportunities
Find the right grant
Search federal, foundation, and corporate grants with AI — or browse by agency, topic, and state.
This listing may be outdated. Verify details at the official source before applying.
Find similar grantsNo fixed deadline mentioned; contact-based application process suggests rolling
NYU Langone Health Venture Fund is sponsored by NYU Langone Health. The NYU Langone Health Venture Fund provides strategic seed-stage investments to biomedical startups that leverage technologies and intellectual property developed at NYU.
Get alerted about grants like this
Save a search for “NYU Langone Health” or related topics and get emailed when new opportunities appear.
Search similar grants →Extracted from the official opportunity page/RFP to help you evaluate fit faster.
NYU Langone Health Venture Fund - Technology Opportunities & Ventures by NYU and NYU Langone Health NYU Langone Health Venture Fund NYU Langone Health Venture Fund Commercialization Process Intellectual Property 101 NYU Innovators’ “Bill of Rights” Therapeutics Alliances (Innovators) Therapeutics Alliances Request for Proposals MedTech Venture Prototyping Technology Acceleration & Commercialization Awards NYU Langone Health Venture Fund Biomedical Entrepreneurship Program Biomedical Entrepreneurship Program Courses The NYU Langone Health Venture Fund provides strategic seed-stage investments to biomedical startups that leverage technologies and IP developed at NYU, including companies developing drugs, diagnostics, medical devices, and healthtech solutions.
With a deep understanding of the healthcare landscape and a commitment to innovation, we offer more than just capital—we provide an ecosystem to drive success. What sets the NYU Langone Health Venture Fund apart?
Healthcare investors with a diverse skillset: Our investment committee is comprised of experienced professionals with a broad range of backgrounds, including practicing physicians, medical researchers, hospital administrators, finance professionals, and biotech executives. We understand the unique challenges and opportunities that healthcare startups face, enabling us to offer tailored guidance to our portfolio companies.
Seed stage focus: We specialize in seed stage investments, recognizing the importance of early-stage funding in propelling healthcare ventures from concept to patients. Value-added support: Beyond financing, we aid our portfolio companies in business development initiatives and by providing access to our network of medical experts.
A strong, focused team: We want leaders with domain expertise who understand the technical, operational, and regulatory challenges in bringing a clinical product to market. We value transparency and management’s ability to communicate promptly and succinctly. Impactful healthcare solutions: Our investment focus is centered around companies that have the potential to address significant unmet needs.
We look for technology that is differentiated, and for entrepreneurs who can articulate the value of their product and how it fits within a competitive landscape. Scientific validation: For therapeutics, we look for a clear mechanism of action and supportive preclinical data. For diagnostics, medical devices, or healthtech solutions, we look for prototypes that can provide early evidence of clinical benefit.
Settled IP: We expect startups to have completed licensing discussions and have access to IP with strong claims that provide freedom to operate. A well-thought-out business model: Management should have a firm grasp of near-term expenses and funds required to advance programs to market. Preliminary market sizing analysis should also be conducted that shows an understanding of addressable commercial opportunities.
Our overriding mission is to help convert the groundbreaking medical discoveries made within the halls of NYU into tangible benefits for patients. If you are a healthcare entrepreneur leveraging NYU IP, contact TOV to learn more about how we can help turn your vision into reality.
Scoring criteria used to review proposals for this grant.
Based on current listing details, eligibility includes: Biomedical startups with strong leadership and domain expertise developing therapeutics, diagnostics, medical devices, or healthtech with settled NYU/NYU Langone IP and preclinical or prototype validation. Applicants should confirm final requirements in the official notice before submission.
Current published award information indicates Seed-stage investments (Varies) Always verify allowable costs, matching requirements, and funding caps directly in the sponsor documentation.
The current target date is rolling deadlines or periodic funding windows. Build your timeline backwards from this date to cover registrations, approvals, attachments, and final submission checks.
Federal grant success rates typically range from 10-30%, varying by agency and program. Build a strong proposal with clear objectives, measurable outcomes, and a well-justified budget to improve your chances.
Requirements vary by sponsor, but typically include a project narrative, budget justification, organizational capability statement, and key personnel CVs. Check the official notice for the complete list of required attachments.
Yes — AI tools like Granted can help research funders, draft proposal sections, and check compliance. However, always review and customize AI-generated content to reflect your organization's unique strengths and the specific requirements of the solicitation.
Review timelines vary by funder. Federal agencies typically take 3-6 months from submission to award notification. Foundation grants may be faster, often 1-3 months. Check the program's timeline in the official solicitation for specific dates.
Many federal programs offer multi-year funding or allow competitive renewals. Check the official solicitation for continuation and renewal policies. Non-competing continuation applications are common for multi-year awards.